These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 663202)

  • 1. Adrenal scanning and uptake with 131I-6beta-iodomethyl-nor-cholesterol.
    Ryo UY; Johnston AS; Kim I; Pinsky SM
    Radiology; 1978 Jul; 128(1):157-61. PubMed ID: 663202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Improved scintigraphic imaging of the adrenals with 6beta-131I-iodomethyl-cholesterol (author's transl)].
    Tragl KH; Angelberger P; Pils P; Wiesinger F; Kletter K
    Rofo; 1977 Oct; 127(4):365-9. PubMed ID: 144660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new and superior adrenal imaging agent, 131I-6beta-iodomethyl-19-nor-cholesterol (NP-59): evaluation in humans.
    Sarkar SD; Cohen EL; Beierwaltes WH; Ice RD; Cooper R; Gold EN
    J Clin Endocrinol Metab; 1977 Aug; 45(2):353-62. PubMed ID: 885997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study of adrenal imaging with 123I-labeled-6 beta-iodomethyl-19-norcholesterol (author's transl)].
    Shishido F; Tateno Y; Ido T; Irie T; Suzuki K; Fukushi K; Iwata R; Kojima M; Maeda M; Ito T; Ogawa H
    Radioisotopes; 1980 Nov; 29(11):526-32. PubMed ID: 7244299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorbed dose to the human adrenals from lodomethylnorcholesterol (I-131) "NP-59": concise communication.
    Carey JE; Thrall JH; Freitas JE; Beierwaltes WH
    J Nucl Med; 1979 Jan; 20(1):60-2. PubMed ID: 430180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship of serum lipids to adrenal-gland uptake of 6 beta-[131I]iodomethyl-19-norcholesterol in Cushing's syndrome.
    Valk TW; Gross MD; Freitas JE; Swanson DP; Schteingart DE; Beierwaltes WH
    J Nucl Med; 1980 Nov; 21(11):1069-72. PubMed ID: 7431105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High thyroid radiation dose associated with 131-I-19-iodocholesterol adrenal scanning.
    O'Connor MK; Cullen MJ; Malone JF
    Br J Radiol; 1979 Feb; 52(614):130-3. PubMed ID: 427363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of 19-iodocholesterol-131I with 6beta-iodomethyl-19-norcholest-5(10)-en-3beta-ol-131I as an adrenal-scanning agent.
    Nitta K; Ogawa H; Ito T; Kojima M; Maeda M
    Chem Pharm Bull (Tokyo); 1976 Oct; 24(10):2322-6. PubMed ID: 1017078
    [No Abstract]   [Full Text] [Related]  

  • 9. Selenium 75 selenomethyl cholesterol: a new agent for quantitative functional scintigraphy of the adrenals: physical aspects.
    Hawkins LA; Britton KE; Shapiro B
    Br J Radiol; 1980 Sep; 53(633):883-9. PubMed ID: 7437711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new and superior adrenal scanning agent, NP-59.
    Sarkar SD; Beierwaltes H; Ice RD; Basmadjian GP; Hetzel KR; Kennedy WP; Mason MM
    J Nucl Med; 1975 Nov; 16(11):1038-42. PubMed ID: 1185265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioisotopic study of the adrenal glands using 131I-19-iodocholesterol.
    Troncone L; Galli G; Salvo D; Barbarino A; Bonomo L
    Br J Radiol; 1977 May; 50(593):340-9. PubMed ID: 861453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The normal dexamethasone-suppression adrenal scintiscan.
    Gross MD; Freitas JE; Swanson DP; Brady T; Beierwaltes WH
    J Nucl Med; 1979 Nov; 20(11):1131-5. PubMed ID: 536772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenal imaging with iodomethyl-norcholesterol (I-131) in primary aldosteronism.
    Freitas JE; Grekin RJ; Thrall JH; Gross MD; Swanson DP; Beierwaltes WH
    J Nucl Med; 1979 Jan; 20(1):7-10. PubMed ID: 430181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure to visualize adrenal glands in a patient with bilateral adrenal hyperplasia.
    Gordon L; Mayfield RK; Levine JH; Lopes-Virella MF; Sagel J; Buse MG
    J Nucl Med; 1980 Jan; 21(1):49-51. PubMed ID: 7356739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 131I-iodocholesterol (NP-59) scintigraphy in adrenocortical diseases.
    Taillefer R; Soucy JP; Eybalin MC; Levasseur A
    J Can Assoc Radiol; 1983 Jun; 34(2):120-4. PubMed ID: 6885882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radionuclide imaging of the adrenal glands.
    Chatal JF; Charbonnel B; Guihard D
    Clin Nucl Med; 1978 Feb; 3(2):71-6. PubMed ID: 657660
    [No Abstract]   [Full Text] [Related]  

  • 17. The diagnosis of Cushing's syndrome using 131I-19-iodocholesterol uptake and adrenal imaging.
    Ortega D; Foz M; Doménech-Torné FM; Tresánchez JM
    Clin Endocrinol (Oxf); 1980 Aug; 13(2):145-9. PubMed ID: 7438469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroidal accumulation of 131I during adrenal gland scintigraphy with 131I-19-iodocholesterol: effects of thyroid blocking agents.
    Barbarino A; Troncone L; Salvo D; Pasargiklian E
    J Clin Endocrinol Metab; 1975 Aug; 41(2):405-7. PubMed ID: 51030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of adrenal gland scanning agents, 6beta-iodomethyl-19-nor-cholest-5(10)-en-3beta-o1-131I (NCL-6-131I) and 131I-19-cholesterol (CL-19-131I)].
    Fukuchi S; Nakajima K; Miura T; Haruyama K; Kida T
    Kaku Igaku; 1976 Dec; 13(6):775-9. PubMed ID: 1035359
    [No Abstract]   [Full Text] [Related]  

  • 20. [Adrenal scintigraphy with 131I-6beta-iodomethyl-19-norcholesterol: good practice guideline].
    Bardet S; Nocaudie-Calzada M; Kraimps JL; Tabarin A; Wémeau JL
    Ann Endocrinol (Paris); 1998 Nov; 59(4):344-53. PubMed ID: 9864556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.